Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
2.
Oncogene ; 36(34): 4929-4942, 2017 08 24.
Article in English | MEDLINE | ID: mdl-28436951

ABSTRACT

Hypoxia plays a critical role during the evolution of malignant cells and tumour microenvironment (TME).Tumour-derived exosomes contain informative microRNAs involved in the interaction of cancer and stromal cells, thus contributing to tissue remodelling of tumour microenvironment. This study aims to clarify how hypoxia affects tumour angiogenesis through exosomes shed from lung cancer cells. Lung cancer cells produce more exosomes under hypoxic conditions than do parental cells under normoxic conditions. miR-23a was significantly upregulated in exosomes from lung cancer under hypoxic conditions. Exosomal miR-23a directly suppressed its target prolyl hydroxylase 1 and 2 (PHD1 and 2), leading to the accumulation of hypoxia-inducible factor-1 α (HIF-1 α) in endothelial cells. Consequently, hypoxic lung cancer cells enhanced angiogenesis by exosomes derived from hypoxic cancer under both normoxic and hypoxic conditions. In addition, exosomal miR-23a also inhibits tight junction protein ZO-1, thereby increasing vascular permeability and cancer transendothelial migration. Inhibition of miR-23a by inhibitor administration decreased angiogenesis and tumour growth in a mouse model. Furthermore, elevated levels of circulating miR-23a are found in the sera of lung cancer patients, and miR-23a levels are positively correlated with proangiogenic activities. Taken together, our study reveals the clinical relevance and prognostic value of cancer-derived exosomal miR-23a under hypoxic conditions, and investigates a unique intercellular communication, mediated by cancer-derived exosomes, which modulates tumour vasculature.


Subject(s)
Capillary Permeability/physiology , Exosomes/metabolism , Lung Neoplasms/metabolism , MicroRNAs/metabolism , Neovascularization, Pathologic/metabolism , Prolyl Hydroxylases/metabolism , Zonula Occludens-1 Protein/metabolism , Animals , Cell Hypoxia/physiology , Cell Line , Cell Line, Tumor , Cell Movement/physiology , Human Umbilical Vein Endothelial Cells , Humans , Hypoxia/metabolism , Lung Neoplasms/pathology , Male , Mice , Mice, Inbred BALB C , Mice, Nude , Tight Junction Proteins/metabolism
3.
Oncogene ; 34(31): 4056-68, 2015 Jul 30.
Article in English | MEDLINE | ID: mdl-25381822

ABSTRACT

Lung cancer is the leading cause of cancer death worldwide, with metastasis underlying majority of related deaths. Angiomotin (AMOT), a scaffold protein, has been shown to interact with oncogenic Yes-associated protein/transcriptional co-activator with a PDZ-binding motif (YAP/TAZ) proteins, suggesting a potential role in tumor progression. However, the functional role of AMOT in lung cancer remains unknown. This study aimed to identify the patho-physiological characteristics of AMOT in lung cancer progression. Results revealed that AMOT expression was significantly decreased in clinical lung cancer specimens. Knockdown of AMOT in a low metastatic CL1-0 lung cancer cell line initiated cancer proliferation, migration, invasion and epithelial-mesenchymal transition. The trigger of cancer progression caused by AMOT loss was transduced by decreased cytoplasmic sequestration and increased nuclear translocation of oncogenic co-activators YAP/TAZ, leading to increased expression of the growth factor, Cyr61. Tumor promotion by AMOT knockdown was reversed when YAP/TAZ or Cyr61 was absent. Further, AMOT knockdown increased the growth and spread of Lewis lung carcinoma in vivo. These findings suggest that AMOT is a crucial suppressor of lung cancer metastasis and highlight its critical role as a tumor suppressor and its potential as a prognostic biomarker and therapeutic target for lung cancer.


Subject(s)
Adaptor Proteins, Signal Transducing/metabolism , Adenocarcinoma/pathology , Cysteine-Rich Protein 61/genetics , Intercellular Signaling Peptides and Proteins/physiology , Lung Neoplasms/pathology , Microfilament Proteins/physiology , Phosphoproteins/metabolism , Transcription Factors/metabolism , Acyltransferases , Adenocarcinoma/genetics , Adenocarcinoma of Lung , Angiomotins , Animals , Cell Cycle Proteins , Cell Line, Tumor , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/metabolism , Cysteine-Rich Protein 61/metabolism , Disease Progression , Down-Regulation/genetics , Gene Expression Regulation, Neoplastic , HEK293 Cells , Humans , Intercellular Signaling Peptides and Proteins/metabolism , Lung Neoplasms/genetics , Membrane Proteins/metabolism , Membrane Proteins/physiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Nude , Microfilament Proteins/metabolism , Protein Binding , YAP-Signaling Proteins
4.
Eur Respir J ; 37(5): 1226-36, 2011 May.
Article in English | MEDLINE | ID: mdl-20817708

ABSTRACT

This study is the first to analyse the soluble factors secreted by the bronchial epithelium after exposure to isophorone diisocyanate (IPDI) that are responsible for increasing migration and proliferation of primary normal human bronchial smooth muscle cells (BSMCs). We treated immortalised, nontumorigenic human bronchial epithelial cells (cell line BEAS-2B) and primary normal human bronchial epithelial cells (HBEC) with IPDI, and then collected the conditioned culture media (IPDI-BEAS-2B-CM and IPDI-HBEC-CM, respectively), which was added to BSMCs. Exposure of BEAS-2B cells and HBECs to IPDI increased interleukin (IL)-8 production. Culture of BSMCs with IPDI-BEAS-2B-CM and IPDI-HBEC-CM increased BSMC proliferation and migration, which are major features in asthma-related airway remodelling. Induction of BSMC proliferation and migration by IPDI-BEAS-2B-CM and IPDI-HBEC-CM was associated with increased focal adhesion kinase (FAK), Src, extracellular signal-regulated kinase (ERK)1/2 and AKT activation. Blocking FAK with a specific inhibitor significantly decreased BSMC migration and proliferation by inhibiting ERK1/2 activation. FAK and ERK1/2 inhibitor also decreased IPDI-BEAS-2B-CM-, IPDI-HBEC-CM- and recombinant human IL-8-mediated BSMC proliferation and migration, whereas blocking Rnd3 using small interfering RNA failed to affect BSMC proliferation, suggesting that Rnd3 was only involved in the regulation of BSMC migration. Our study suggests that inhibition of IL-8 or IL-8-mediated FAK/ERK/Rnd3 signalling is an attractive therapeutic target for IPDI-mediated asthma.


Subject(s)
Interleukin-8/biosynthesis , Interleukin-8/metabolism , Isocyanates/pharmacology , Muscle, Smooth/drug effects , Signal Transduction/drug effects , Bronchi/drug effects , Bronchi/metabolism , Cell Line , Cell Movement/drug effects , Cell Proliferation/drug effects , Cells, Cultured , Enzyme Inhibitors/pharmacology , Focal Adhesion Protein-Tyrosine Kinases/antagonists & inhibitors , Focal Adhesion Protein-Tyrosine Kinases/biosynthesis , Humans , Mitogen-Activated Protein Kinase 1/biosynthesis , Mitogen-Activated Protein Kinase 3/biosynthesis , Proto-Oncogene Proteins c-akt/biosynthesis , RNA, Small Interfering/pharmacology , rho GTP-Binding Proteins/antagonists & inhibitors , rho GTP-Binding Proteins/biosynthesis , src-Family Kinases/biosynthesis
6.
Cancer Gene Ther ; 13(8): 746-52, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16410824

ABSTRACT

Antitumor vaccination therapies using attenuated Salmonella typhimurium carrying plasmid DNA encoding tumor-associated antigens are currently under preclinical development. In the present study, we first established a useful method to facilitate in vivo monitoring of attenuated S. typhimurium uptake using a bioluminescent lux gene operon plasmid. Following transformation with the lux gene operon construct, mice were fed with various amounts of attenuated S. typhimurium-lux to monitor in vivo clearance over a period of 24 h. We found that the ingested attenuated S. typhimurium-lux cells were almost cleared out 9 h postfeeding, as judged by a significant decrease in bioluminescence. We further examined the therapeutic efficacy of vaccination using attenuated S. typhimurium carrying the mouse alpha-fetoprotein (AFP) gene against a cancer line CT26-murine alpha-feto protein (mAFP) that stably expresses AFP and mouse hepatocellular carcinoma (HCC) Hepa1-6. Attenuated S. typhimurium oral DNA vaccine was found to promote protective immunity against both CT26-mAFP and Hepa1-6 tumor cells growth. The oral DNA vaccine significantly increased the life span of tumor-challenged mice in both tumor models. Together, these results suggest that vaccination with the attenuated S. typhimurium oral DNA vaccine that carries the AFP gene could be a promising strategy to prevent HCC development.


Subject(s)
Carcinoma, Hepatocellular/prevention & control , Liver Neoplasms/prevention & control , Salmonella typhimurium/immunology , Vaccines, DNA/immunology , alpha-Fetoproteins/genetics , Administration, Oral , Animals , Antigens, Neoplasm/immunology , Carcinoma, Hepatocellular/immunology , Cell Line , Cell Line, Tumor , Colonic Neoplasms/immunology , Colonic Neoplasms/prevention & control , Cytotoxicity, Immunologic , Genes, Bacterial , Humans , Immune Tolerance , Liver Neoplasms/immunology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Operon , Plasmids , Salmonella typhimurium/genetics , T-Lymphocytes/immunology , Vaccines, Attenuated , Vaccines, DNA/administration & dosage , Xenograft Model Antitumor Assays , alpha-Fetoproteins/immunology
7.
Int J Cancer ; 71(2): 213-7, 1997 Apr 10.
Article in English | MEDLINE | ID: mdl-9139845

ABSTRACT

Deletions involving the chromosome 9p21 region have been reported as frequent events in non-small cell lung cancer (NSCLC). To investigate potential tumor-suppressor gene (TSG) loci within the 9p21 region, which also harbors the candidate TSG locus CDKN2a, we studied 32 cases of primary NSCLC for loss of heterozygosity (LOH). Tumor and paired normal lung cells were microdissected from lung tissue imprints and all samples screened using PCR-LOH analysis with 15 9p markers. In addition, 3 NSCLC cell lines and their matched normal lung and tumor DNA were similarly analyzed. LOH at the marker D9S259, which is proximal to the CDKN2a locus, was found most frequently (52%), while LOH at D9S942, the marker closest (5 kb) to the CDKN2a gene, was seen in only 17%. Homozygous loss of markers close to CDKN2a was, however, detected in 2 of the 3 cell lines and one accompanying tumor sample. We propose that a TSG in the region of deletion proximal to the CDKN2a gene within 9p21 may play a significant role in the pathogenesis and progression of NSCLC.


Subject(s)
Carcinoma, Non-Small-Cell Lung/genetics , Carrier Proteins/genetics , Chromosome Deletion , Chromosomes, Human, Pair 9/genetics , Heterozygote , Lung Neoplasms/genetics , Cyclin-Dependent Kinase Inhibitor p16 , DNA, Neoplasm/analysis , Genes, Tumor Suppressor/genetics , Humans , Lung/physiology , Microsatellite Repeats , Polymerase Chain Reaction , Tumor Cells, Cultured
8.
J Natl Cancer Inst ; 87(16): 1224-9, 1995 Aug 16.
Article in English | MEDLINE | ID: mdl-7563168

ABSTRACT

BACKGROUND: Carcinogenesis is a multistep process, which may begin as a consequence of chromosomal changes. Deletions in the short arm of chromosome 9 (9p) have been observed in lung carcinomas. In addition, morphologically recognizable preneoplastic lesions, frequently multiple in number, precede onset of invasive carcinomas. PURPOSE: We tested for deletions and loss of heterozygosity (LOH) at 9p loci in preneoplastic and neoplastic foci in lungs of patients with non-small-cell lung carcinomas (NSCLCs). METHODS: Seven archival, paraffin-embedded, surgically resected NSCLC specimens were selected. They were predominantly from patients with adenocarcinomas and contained multiple preneoplastic lesions, including hyperplasia, metaplasia, dysplasia, and carcinoma in situ (CIS). Fifty-three histologically identified preneoplastic and malignant lesions present in bronchi, bronchioles, and alveoli were precisely microdissected from stained tissue sections with a micromanipulator. Stromal lymphocytes were used to determine constitutional heterozygosity. The specimens were analyzed for LOH using polymerase chain reaction-based assays for polymorphism in dinucleotide repeats (microsatellite markers) in interferon alfa (IFNA) and D9S171 loci on 9p. RESULTS: All seven cases were constitutionally heterozygous for one or both microsatellite markers. Five of seven cases had LOH at one or both 9p loci in the invasive primary cancers (doubly informative cases). Four of these five cases also revealed LOH in preneoplastic foci. In the doubly informative cases, LOH was detected in five (38%) of 13 foci of hyperplasia, four (80%) of five foci of dysplasia, and three (100%) of three CIS lesions. LOH was detected in preneoplastic lesions from all regions of the respiratory tract, including bronchi, bronchioles, and alveoli, and involved five different cell types. The identical allele was lost from both the preneoplastic lesions and the corresponding tumors (12 of 12 lesions, 17 of 17 comparisons), a phenomenon we have referred to as "allele-specific mutation." Statistical analyses employing a cumulative binomial test demonstrated that the probabilities of such findings occurring by chance are 2.4 x 10(-4) and 7.6 x 10(-6), respectively. From comparisons with the previously published data on other chromosomal abnormalities in the same tissue specimens, it appears that LOH at 3p and 9p loci occurred early in the hyperplasia stage, but the ras gene point mutations were relatively late, at the CIS stage. CONCLUSIONS: LOH at 9p loci occurs at the earliest stage in the pathogenesis of lung cancer and involves all regions of the respiratory tract. LOH in NSCLC is not random but targets a specific allele in individuals. Studying preneoplastic lesions may help identify intermediate markers for risk assessment and chemoprevention.


Subject(s)
Alleles , Carcinoma, Non-Small-Cell Lung/genetics , Chromosome Deletion , Chromosomes, Human, Pair 8/genetics , Lung Neoplasms/genetics , Paraneoplastic Syndromes/genetics , Adenocarcinoma/genetics , Aged , Aged, 80 and over , Base Sequence , Carcinoma, Non-Small-Cell Lung/complications , Female , Genes, ras/genetics , Heterozygote , Humans , Lung Neoplasms/complications , Male , Middle Aged , Molecular Sequence Data , Mutation , Paraneoplastic Syndromes/complications
9.
Cancer Res ; 54(22): 5811-5, 1994 Nov 15.
Article in English | MEDLINE | ID: mdl-7954406

ABSTRACT

We investigated preneoplastic lesions associated with lung cancer to determine at what stage in lung carcinogenesis K-ras mutations appear. We selected six archival lung cancer resection cases that had ras mutations. We precisely microdissected 74 relevant areas from paraffin-embedded sections. K-ras mutations at codons 12, 13, and 61 were determined by the designed restriction fragment length polymorphism method using mismatched nested primers and confirmed by direct sequencing. All samples of invasive and metastatic cancers had K-ras mutations, as did four of five lesions of noninvasive cancer. Mutations were detected in only 1 of 12 dysplastic lesions and were absent from hyperplastic and normal-appearing cells. In all cases, the specific point mutations and the mutational pattern in the tumors, metastases, and the corresponding noninvasive lesions were identical. These results indicate that K-ras mutations arise relatively late in the pathogenesis of lung cancer and may be associated with the appearance of the malignant phenotype.


Subject(s)
Carcinoma, Non-Small-Cell Lung/genetics , Genes, ras/genetics , Lung Neoplasms/genetics , Point Mutation/genetics , Precancerous Conditions/genetics , Codon/genetics , Humans , Polymorphism, Restriction Fragment Length
10.
Am Rev Respir Dis ; 146(6): 1458-61, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1280929

ABSTRACT

Fluorescence bronchoscopy was performed in 82 volunteers recruited from occupational groups at risk of exposure to asbestos and/or diesel fumes to determine whether differences in tissue autofluorescence between normal and malignant bronchial tissues can be used to improve the sensitivity of standard fiberoptic bronchoscopy in detecting dysplasic and carcinoma in situ (CIS). This study consisted of 25 nonsmokers, 40 exsmokers, and 17 current smokers with mean ages of 52, 55, and 49 yr, respectively. Tissue autofluorescence was induced by a blue light from an He-Cd laser coupled to the illumination channel of the bronchoscope and analyzed by a ratiofluorometer. One or more sites of moderate or severe dysplasia were found in 12% of the exsmokers and current smokers but in none of the nonsmoker volunteers. CIS was found in two of the exsmokers. The sensitivity of fluorescence bronchoscopy (86%) was found to be 50% better than that of conventional white-light bronchoscopy (52%) in detecting dysplasia and CIS. Pre- and post-bronchoscopy sputum cytology failed to detect these precancerous lesions. Our results suggest that fluorescence bronchoscopy may be an important new method that can improve the ability to detect and localize precancerous and/or CIS lesions.


Subject(s)
Carcinoma in Situ/diagnosis , Fluorometry , Lung Neoplasms/diagnosis , Occupational Diseases/diagnosis , Asbestos/adverse effects , Biopsy, Needle , Bronchi/pathology , Bronchoscopy , Carcinoma in Situ/etiology , Carcinoma in Situ/pathology , Fluorescence , Humans , Lung Neoplasms/etiology , Lung Neoplasms/pathology , Middle Aged , Occupational Diseases/etiology , Occupational Diseases/pathology , Risk Factors , Sensitivity and Specificity , Smoking , Vehicle Emissions/adverse effects
11.
Ann Ophthalmol ; 19(8): 313-5, 318, 1987 Aug.
Article in English | MEDLINE | ID: mdl-3662317

ABSTRACT

We compared the rate of recovery of corneal sensation in two randomly selected groups of patients with rhegmatogenous retinal detachment whose eyes were otherwise healthy. One of the groups underwent removal of the epithelium and, and the other was characterized by nonremoval of the epithelium. The corneal sensations were measured serially with an esthesiometer. The return of corneal sensation occurred sooner in the nonremoval group than in the removal group in the early postoperative period, but at three months, the difference was negligible.


Subject(s)
Cornea/physiology , Retinal Detachment/surgery , Sensation/physiology , Epithelium/physiology , Humans , Postoperative Period , Random Allocation
13.
Ann Ophthalmol ; 12(9): 1054-5, 1980 Sep.
Article in English | MEDLINE | ID: mdl-6085608

ABSTRACT

A patient with X-linked juvenile retinoschisis was followed from age 5 years. At age 15 he developed rubeosis iridis and neovascular glaucoma in one eye, resulting in no light perception. A review of the literature revealed this case to be the first reported association of X-linked juvenile retinoschisis and neovascular glaucoma.


Subject(s)
Glaucoma/etiology , Retinal Diseases/genetics , X Chromosome , Adolescent , Female , Genetic Linkage , Humans , Iris/blood supply , Male , Neovascularization, Pathologic , Retinal Diseases/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...